VacciNEWS – Page 28 – Global Health Press

GHP News Infographic

Rabies

Fill Form & Download Overview Rabies is the deadliest disease known to mankind and yet it is virtually 100% vaccine-preventable. There are no known cures for rabies once clinical symptoms are evident. Over 95% of...

17 September, 2025

1 min read

GHP News Latest Science

Dynamics of influenzas vaccine induced antibodies – what can we learn?

Lane A, Quach HQ, Ovsyannikova IG, Kennedy RB, Ross TM, Einav T. High-resolution antibody dynamics following influenza vaccination reveal predominantly weak responses as well as infrequent but durable immunity across...

16 September, 2025

3 min read

GHP News Latest Science

US government drastically reduces mRNA vaccine research funding

Petersen E, Ippolito G, Maeurer M, Ntoumi F, Nachega JB, Hui DS, Zumla A. Protecting the future of vaccine development amidst US funding withdrawal for mRNA vaccine research. Lancet Microbe. Published online August 2025...

16 September, 2025

4 min read

GHP News Latest Science

Measles outbreak in Sudan

Azhary A, Hajhamed NM, Osman Ali ET, Muvunyi CM, Siddig EE. Resurgent multistate measles outbreak in Sudan amidst conflict: Urgent need for vaccination and international support. Int J Infect Dis. 2025. doi:10.1016/j...

16 September, 2025

3 min read

GHP News Infographic

Poliomyelitis

Fill Form & Download Overview Wild poliovirus (WPV) comprises 3 serotypes (1, 2, 3), which may infect and destroy spinal the lower motor neurons. PV is shed via salivary droplets and feces, and it is transmitted...

10 September, 2025

1 min read

GHP News Latest Science

Self-testing for 5 respiratory viruses in adult VACCELERATE volunteers in Germany—a pilot study on multi-pathogen rapid antigen testing to monitor community-acquired acute respiratory infections

This prospective pilot study assessed the real-time epidemiology of acute respiratory infections (ARI) in Germany using self-administered, multi-pathogen antigen rapid testing among adult volunteers from the VACCELERATE...

9 September, 2025

3 min read

GHP News Latest Science

RSV prefusion F vaccine for prevention of hospitalization in older adults

The DAN-RSV phase 4 pragmatic randomized trial evaluated the effectiveness and safety of the bivalent RSV prefusion F protein–based vaccine (RSVpreF) in adults aged 60 years and older during the 2024–2025 season in...

9 September, 2025

2 min read

GHP News Latest Science

The Japanese experience with vaccinating schoolchildren against influenza

The landmark study by Reichert et al. (2001) systematically analyzed the impact of Japan’s national policy to vaccinate schoolchildren against influenza on overall and pneumonia/influenza-associated mortality, spanning...

9 September, 2025

3 min read

All Articles